Publications
Publications
  • February 1986 (Revised November 1992)
  • Case
  • HBS Case Collection

Novo Industri A/S--1981

By: W. Carl Kester and Glynn Ferguson
  • Format:Print
  • | Pages:12
ShareBar

Abstract

This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of issues concerning the ability of a multinational company to lower its cost of capital by tapping different capital markets worldwide.

Keywords

Capital Markets; Cost of Capital; Bonds; Stock Shares; Financing and Loans; Globalization; Biotechnology Industry; Chemical Industry; Denmark; United States

Citation

Kester, W. Carl, and Glynn Ferguson. "Novo Industri A/S--1981." Harvard Business School Case 286-084, February 1986. (Revised November 1992.)

About The Author

W. Carl Kester

Finance
More Publications

More from the Authors